High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse-Reference-Cited by-同舟云学术

High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse

Published:2021-07-09 Issue:2 Volume:195 Page:283-286
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Boyle Eileen M.¹^ORCID,Rosenthal Adam²,Wang Yan³,Farmer Philip³,Rutherford Michael³,Ashby Cody³,Bauer Michael³,Johnson Sarah K.⁴,Wardell Christopher P.³,Hoering Antje²,Schinke Carolina⁴,Thanendrarajan Sharmilan⁴,Zangari Maurizio⁴^ORCID,Barlogie Bart⁴,Davies Faith E.¹,Walker Brian A.⁵,Rhee Frits³,Morgan Gareth J.¹

Affiliation:

1. Perlmutter Cancer Center NYU Langone Medical Center Myeloma Research Program New York NYUSA

2. Cancer Research and Biostatistics – CRAB SeattleUSA

3. Department of Biomedical Informatics University of Arkansas for Medical Sciences Little Rock AR USA

4. Myeloma Center University of Arkansas for Medical Sciences Little Rock ARUSA

5. Melvin and Bren Simon Comprehensive Cancer Center Division of Hematology Oncology Indiana University Indianapolis IN USA

Funder

Fondation de France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17670

Reference7 articles.

1. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

2. The molecular classification of multiple myeloma

3. A gene expression signature for high-risk multiple myeloma

4. Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome

5. Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes;Nature Genetics;2024-08-19

2. Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification;Scientific Reports;2024-07-02

3. Approach to High-Risk Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

4. Perspectives on the Risk-Stratified Treatment of Multiple Myeloma;Blood Cancer Discovery;2022-06-02

5. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence;Leukemia;2022-05-28